Enhancing Intensive Transdiagnostic Cognitive Behavioral Therapy for Veterans with PTSD and Anxiety Disorders

reportActive / Technical Report | Accesssion Number: AD1216547 | Open PDF

Abstract:

We have no findings to report in Year 1 of this study. This randomized controlled trial tests an innovative transdiagnostic cognitive behavioral treatment (TCBT) for Veterans and Service members with PTSD and anxiety. This project examines the effectiveness of the treatment delivered in a weekend group format or 2-week individual format. Treatment non-responders receive 6 additional hours of treatment. Primary study aims are to examine the effectiveness of: (1) group and individual iTCBT in improving anxiety symptoms and quality of life and (2) the enhanced treatment in improving anxiety symptoms and quality of life for those who do not initially respond to treatment. A total of 306 Veterans, Active Duty, and Reservists with a diagnosis of PTSD and/or an anxiety disorder will be randomized to receive the treatment either in a two-day (e.g., weekend) group format or a 2-week individual format. Those randomized to a third condition will receive treatment-as-usual. Assessments are completed at three time points: baseline and 3- and 6-month follow-ups. Primary study outcomes include measures of anxiety and quality of life at 6-month follow-up.

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution Code:
A - Approved For Public Release
Distribution Statement: Public Release.
Copyright: Not Copyrighted

RECORD

Collection: TRECMS
Subject Terms